The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The m-RNA Synthesis Service Market Projected To Reach By 2030?
The m-rna synthesis service market has demonstrated robust expansion over recent years. Its valuation is set to climb from $4.99 billion in 2025 to $5.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. The notable growth observed in the preceding period is attributable to several factors, including the expedited progress of vaccine research programs, increased financial support for genetic research, the broadening scope of contract research services, the expanding integration of mrna into academic studies, and enhancements in transcription efficiency technologies.
The m-rna synthesis service market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $7.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. The projected growth during this period stems from factors such as an expanding pipeline of mRNA-based treatments, a heightened need for tailored medicine options, the broadening of gene therapy investigations, an increasing dependency on outsourced synthesis services, and more frequent regulatory endorsements for mRNA products. Key trends anticipated for the forecast timeframe encompass an increasing requirement for customized mRNA constructs, greater integration of GMP-grade mRNA manufacturing, wider application of scalable in vitro transcription platforms, the proliferation of expedited synthesis services, and a heightened emphasis on producing high-purity mRNA.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24611&type=smp
Which Key Drivers Are Affecting The m-RNA Synthesis Service Market Development?
The growing emphasis on personalized medicine is anticipated to drive the expansion of the mRNA synthesis service market. This medical strategy involves customizing treatments and healthcare choices based on an individual’s unique genetic profile, lifestyle, and environmental factors. Its rise is attributed to progress in genomic sequencing, which enables more accurate identification of individual genetic variations associated with diseases and how patients respond to treatment. mRNA synthesis services contribute to this trend by facilitating the swift and precise creation of mRNA-based therapies, specifically designed for a patient’s genetic composition, leading to more efficacious and targeted interventions. As an illustration, the Personalized Medicine Coalition, a US-based non-profit organization, reported in February 2024 that the FDA cleared 16 new personalized treatments for rare diseases in 2023. This marks a substantial increase from the 6 approvals in 2022, with seven of these being cancer medications and three addressing other illnesses and conditions. Consequently, the heightened attention on personalized medicine is fueling the growth of the mRNA synthesis service market.
How Are Different Segments Classified In The m-RNA Synthesis Service Market Segment Analysis?
The m-rna synthesis service market covered in this report is segmented –
1) By Type: mRNA Vaccine Synthesis, mRNA Drug Synthesis
2) By Application Area: Vaccine Development, Therapeutic Development, Research and Development, Diagnostics
3) By End-user Industry: Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutions, Contract Research Organizations (CROs)
Subsegments:
1) By mRNA Vaccine Synthesis: Infectious Disease Vaccines, Cancer Vaccines, Personalized Vaccines
2) By mRNA Drug Synthesis: Protein Replacement Therapies, Gene Editing Therapeutics, Cell Therapy Support
What Trends Are Transforming The m-RNA Synthesis Service Market?
Leading companies within the mRNA synthesis service market are concentrating on creating cutting-edge solutions, particularly RNA polymerase innovations, to boost the efficiency, output, and safety of mRNA production. RNA polymerase innovations involve the creation of advanced enzymes designed to improve the transcription process, reduce adverse effects such as the formation of double-stranded RNA, and elevate the overall quality of mRNA essential for vaccines and therapeutic applications. For example, in March 2025, Primrose Bio Inc., a US-based biotechnology firm, introduced Prima RNApols to enhance the effectiveness and scalability of mRNA synthesis. This enzyme offers improved processivity and accurate transcription, enabling the generation of longer, more stable mRNA strands with reduced error rates. Its strong performance in in vitro transcription systems helps minimize contaminants and increase overall yield, providing a dependable and scalable option for businesses involved in developing mRNA-based drugs. This advancement is especially significant in the expanding field of personalized medicine, where precise and efficient mRNA synthesis is vital.
Who Are The Companies Driving Activity In The m-RNA Synthesis Service Market?
Major companies operating in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, APExBIO Technology LLC
Get The Full m-RNA Synthesis Service Market Report:
https://www.thebusinessresearchcompany.com/report/m-rna-synthesis-service-global-market-report
Which Region Leads The m-RNA Synthesis Service Market In Overall Market Size?
North America was the largest region in the m-RNA synthesis service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the m-rna synthesis service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized m-RNA Synthesis Service Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/m-rna-synthesis-service-global-market-report
Browse Through More Reports Similar to the Global m-RNA Synthesis Service Market 2026, By The Business Research Company
Contrast Media Market Report 2026
https://www.thebusinessresearchcompany.com/report/contrast-media-global-market-report
Medical Imaging Market Report
https://www.thebusinessresearchcompany.com/report/medical-imaging-global-market-report
Portable Magnetic Resonance Imaging Mri Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model